瑞陽制藥有限公司創建于1966年，目前總資產達30億元，員工超過4000人。公司總部設在山東沂源，并在上海松江區設有分公司，在總部、濟南、上海和美國設有研發中心。160多個辦事處遍布國內大中城市，產品已覆蓋全國，并遠銷德國、法國、韓國等三十多個國家。
瑞陽的業務領域主要包括藥品的研發與制造。涉及粉針制劑、原料藥、固體制劑和中藥制劑的生產和研發，以及抗癌藥物、新的抗生素類藥物、防疫疫苗和治療疫苗等的研發。是全國大的頭孢類原料藥生產基地之一，粉針生產規模全國前五，其梅洛西林鈉原料藥及其制劑。同時，與清華大學、山東大學等30多家高校和科研機構有著常年科研合作關系，擁有大量專利產品，獲得國家科技進步獎，承擔國家級項目5項，并負責起草了42個新藥產品的國家藥品標準。
四十多年來，秉承“瑞陽制藥，造福四方”的宗旨，瑞陽制藥有限公司重視新產品、新技術的開發，以嚴密的質保體系為保障，保持效益持續穩定的增長，并積極參與社會公益事業，位列中國的制藥工業企業前20強。在未來，瑞陽制藥將繼續以優質的產品造福社會。
隨著公司的發展，我們將不斷創造高質量的就業機會，誠邀有志之士加盟我們的團隊。
Reyoung Pharmaceutical Co., Ltd, which was converted into a limited company under the PRC law in 1998 and is now a Singapore-listed company, was established in 1966. The company is an ISO9001、ISO14001、OHS18001 authentication enterprise and possess postdoctoral programme and ERP system and so on. The trademark of “reyoung” is famous trademark of China.
reyoung
It covers an area of more than 343,000 square meters, with the total asset of USD500 millions. There is more than 4000 staff in Reyoung Pharm., of whom approximate 21 percents of the total staff is sales&marketing personnel. All the workshops, which can produce eight categories and more than 340 specifications of pharmaceutical products including tablets, capsules, granules, sterile active ingredients, small volume injection, powder for injection, lyophilized powder for injection, suppository, have passed GMP certification of the Chinese SFDA. The sales and marketing network for its products covers all the big and medium cities throughout the mainland of PRC.